Fig. 3From: Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT2R2 scoreCumulative incidence of efficacy and safety outcomes of atrial fibrillation patients compared between those taking warfarin and those taking NOACs among A all patients taking oral anticoagulants, B patients with a low SAMe-TT2R2 score (range: 0–2), and C patients with a high SAMe-TT2R2 score (range: 3–8)Back to article page